Zhang, Y., Kubiak, A. M., Bailey, T. S., Claessen, L., Hittmeyer, P., Dubois, L., Theys, J., & Lambin, P. (2023). Development of a CRISPR-Cas12a system for efficient genome engineering in clostridia. Microbiology spectrum, 11(6), Article 0245923. https://doi.org/10.1128/spectrum.02459-23
Kubiak, A. M., Claessen, L., Zhang, Y., Khazaie, K., & Bailey, T. S. (2023). Refined control of CRISPR-Cas9 gene editing in Clostridium sporogenes: the creation of recombinant strains for therapeutic applications. Frontiers in Immunology, 14, Article 1241632. https://doi.org/10.3389/fimmu.2023.1241632
Bailey, T. S., Hittmeyer, P., Zhang, Y., & Kubiak, A. M. (2023). Streamlined assembly of cloning and genome editing vectors for genus Clostridium. iScience, 26(8), Article 107484. https://doi.org/10.1016/j.isci.2023.107484
Kubiak, A. M., van de Laak, J., Zhang, Y., Bailey, T. S., Claessen, L., Hittmeyer, P., Vlaswinkel, C., Mowday, A., Dubois, L. J., & Theys, J. (2023). Clostridia as live biotherapeutics: can modified Clostridium species enhance disease treatments?Future Microbiology, 18(7), 385-388. https://doi.org/10.2217/fmb-2022-0220
Zhang, Y., Bailey, T. S., Kubiak, A. M., Lambin, P., & Theys, J. (2022). Heterologous Gene Regulation in Clostridia: Rationally Designed Gene Regulation for Industrial and Medical Applications. ACS Synthetic Biology, 11(11), 3817–3828. https://doi.org/10.1021/acssynbio.2c00401